RACHEL SPOONHOWER: Open Payments
NPI 1609164805 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 29 payments from 17 companies in 2025. Trend: 2023 $553 · 2024 $534 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $100 |
| Dexcom, Inc. | 2 | $83 |
| ABBVIE INC. | 3 | $67 |
| PFIZER INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Abbott Laboratories | 2 | $38 |
| SANOFI PASTEUR INC. | 1 | $31 |
| Neuronetics, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Verona Pharma, Inc. | 1 | $28 |
Products named: Dexcom G6 Transmitter, UBRELVY, PREVNAR 20, FREESTYLE LIBRE 3, SHINGRIX, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, NEUROSTAR TMS THERAPY SYSTEM, JARDIANCE.
Industry payments across PA — which companies pay providers there.
